First Time Loading...

Pcas SA
PAR:PCA

Watchlist Manager
Pcas SA Logo
Pcas SA
PAR:PCA
Watchlist
Price: 8 EUR Market Closed
Updated: May 8, 2024

Intrinsic Value

PCAS SA engages in the development, manufacture, and sale of chemicals. [ Read More ]

The intrinsic value of one PCA stock under the Base Case scenario is 14.64 EUR. Compared to the current market price of 8 EUR, Pcas SA is Undervalued by 45%.

Key Points:
PCA Intrinsic Value
Base Case
14.64 EUR
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Pcas SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PCA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Pcas SA

Provide an overview of the primary business activities
of Pcas SA.

What unique competitive advantages
does Pcas SA hold over its rivals?

What risks and challenges
does Pcas SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pcas SA.

Provide P/S
for Pcas SA.

Provide P/E
for Pcas SA.

Provide P/OCF
for Pcas SA.

Provide P/FCFE
for Pcas SA.

Provide P/B
for Pcas SA.

Provide EV/S
for Pcas SA.

Provide EV/GP
for Pcas SA.

Provide EV/EBITDA
for Pcas SA.

Provide EV/EBIT
for Pcas SA.

Provide EV/OCF
for Pcas SA.

Provide EV/FCFF
for Pcas SA.

Provide EV/IC
for Pcas SA.

Show me price targets
for Pcas SA made by professional analysts.

What are the Revenue projections
for Pcas SA?

How accurate were the past Revenue estimates
for Pcas SA?

What are the Net Income projections
for Pcas SA?

How accurate were the past Net Income estimates
for Pcas SA?

What are the EPS projections
for Pcas SA?

How accurate were the past EPS estimates
for Pcas SA?

What are the EBIT projections
for Pcas SA?

How accurate were the past EBIT estimates
for Pcas SA?

Compare the revenue forecasts
for Pcas SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pcas SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pcas SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pcas SA compared to its peers.

Compare the P/E ratios
of Pcas SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Pcas SA with its peers.

Analyze the financial leverage
of Pcas SA compared to its main competitors.

Show all profitability ratios
for Pcas SA.

Provide ROE
for Pcas SA.

Provide ROA
for Pcas SA.

Provide ROIC
for Pcas SA.

Provide ROCE
for Pcas SA.

Provide Gross Margin
for Pcas SA.

Provide Operating Margin
for Pcas SA.

Provide Net Margin
for Pcas SA.

Provide FCF Margin
for Pcas SA.

Show all solvency ratios
for Pcas SA.

Provide D/E Ratio
for Pcas SA.

Provide D/A Ratio
for Pcas SA.

Provide Interest Coverage Ratio
for Pcas SA.

Provide Altman Z-Score Ratio
for Pcas SA.

Provide Quick Ratio
for Pcas SA.

Provide Current Ratio
for Pcas SA.

Provide Cash Ratio
for Pcas SA.

What is the historical Revenue growth
over the last 5 years for Pcas SA?

What is the historical Net Income growth
over the last 5 years for Pcas SA?

What is the current Free Cash Flow
of Pcas SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pcas SA.

Financials

Balance Sheet Decomposition
Pcas SA

Current Assets 150.1m
Cash & Short-Term Investments 266k
Receivables 74.6m
Other Current Assets 75.3m
Non-Current Assets 151.7m
Long-Term Investments 117k
PP&E 148.7m
Intangibles 2.9m
Other Non-Current Assets 41k
Current Liabilities 217.1m
Accounts Payable 33.6m
Accrued Liabilities 23.4m
Other Current Liabilities 160m
Non-Current Liabilities 77.6m
Long-Term Debt 67.9m
Other Non-Current Liabilities 9.7m
Efficiency

Earnings Waterfall
Pcas SA

Revenue
230m EUR
Cost of Revenue
-145.9m EUR
Gross Profit
84.1m EUR
Operating Expenses
-110.5m EUR
Operating Income
-26.4m EUR
Other Expenses
35.2m EUR
Net Income
8.8m EUR

Free Cash Flow Analysis
Pcas SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PCA Profitability Score
Profitability Due Diligence

Pcas SA's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
Positive Gross Profit
ROE is Increasing
Exceptional 1-Year Revenue Growth
34/100
Profitability
Score

Pcas SA's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

PCA Solvency Score
Solvency Due Diligence

Pcas SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Positive Net Debt
High D/E
25/100
Solvency
Score

Pcas SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PCA Price Targets Summary
Pcas SA

Wall Street analysts forecast PCA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCA is 14.5 EUR .

Lowest
Price Target
Not Available
Average
Price Target
14.5 EUR
81% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PCA Price
Pcas SA

1M 1M
-
6M 6M
+0%
1Y 1Y
+14%
3Y 3Y
-37%
5Y 5Y
+40%
10Y 10Y
+391%
Annual Price Range
8
52w Low
6.45
52w High
8.5
Price Metrics
Average Annual Return 19.33%
Standard Deviation of Annual Returns 55.35%
Max Drawdown -60%
Shares Statistics
Market Capitalization 109.9m EUR
Shares Outstanding 13 741 673
Percentage of Shares Shorted
N/A

PCA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Pcas SA Logo
Pcas SA

Country

France

Industry

Life Sciences Tools & Services

Market Cap

109.9m EUR

Dividend Yield

0%

Description

PCAS SA engages in the development, manufacture, and sale of chemicals. The company is headquartered in Ecully, Auvergne-Rhone-Alpes. The company operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The firm operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.

Contact

AUVERGNE-RHONE-ALPES
Ecully
21 Chemin de la Sauvegarde, Ecully Cedex
+33169097785
http://www.pcas.com/

IPO

1995-04-05

Employees

1 180

Officers

Acting CEO & Director
Mr. Jean-Louis Martin
Gen. Director of Fin. & Admin.
Mr. Eric Moissenot
Scientific Director
Mr. Gérard Guillamot
Head of R&D
Mr. Christophe Eychenne-Baron
Deputy Managing Director of BU Fine Chemistry
Mr. Sebastien Taillemite
Chief Exec. Officer of Protéus
Ms. Juliette Martin

See Also

Discover More
What is the Intrinsic Value of one PCA stock?

The intrinsic value of one PCA stock under the Base Case scenario is 14.64 EUR.

Is PCA stock undervalued or overvalued?

Compared to the current market price of 8 EUR, Pcas SA is Undervalued by 45%.